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Abstract
A large quantitative study was carried out to compare the proteome of respiratory syncytial virus (RSV) infected
versus uninfected cells in order to determine novel pathways regulated during viral infection. RSV infected and
mock-infected HEp2 cells were lysed and proteins separated by preparative isoelectric focussing using offgel
fractionation. Following tryptic digestion, purified peptides were characterized using label-free quantitative
expression profiling by nano-ultra performance liquid chromatography coupled to electrospray ionisation mass
spectrometry with collision energy ramping for all-ion fragmentation (UPLC-MS
E). A total of 1352 unique cellular
proteins were identified and their abundance compared between infected and non-infected cells. Ingenuity
pathway analysis revealed regulation of several central cellular metabolic and signalling pathways during infection.
Selected proteins that were found regulated in RSV infected cells were screened by quantitative real-time PCR for
their regulation on the transcriptional level. Synthesis of interferon-induced protein with tetratricopeptide repeats 3
(IFIT3) and 5’-3’-exoribonuclease 2 (XRN2) mRNAs were found to be highly induced upon RSV infection in a time
dependent manner. Accordingly, IFIT3 protein levels accumulated during the time course of infection. In contrast,
little variation was observed in XRN2 protein levels, but different forms were present in infected versus non-
infected cells. This suggests a role of these proteins in viral infection, and analysis of their function will shed further
light on mechanisms of RNA virus replication and the host cell defence machinery.
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Background
Human respiratory syncytial virus (RSV) is a pathogen
of the family of Paramyxoviridae, causing severe infec-
tion of the lower respiratory tract predominantly in
young children and the elderly. It is well recognized to
be responsible for the majority of paediatric hospitaliza-
tions due to lower respiratory tract illness such as
bronchiolitis and pneumonia. Although vaccines have
been successfully developed for other members of the
Paramyxovirus family such as Measles virus, vaccination
against RSV infection remains challenging: RSV induced
protective immune responses are short lasting and also
show effects of enhancing disease severity of secondary
infections [1]. However, specific preventative treatment
with monoclonal antibody preparations against the viral
fusion (F) surface protein can be given to high risk chil-
dren during annual epidemic peak periods. Nonetheless,
there is evidence that most hospitalized children are
completely healthy prior to RSV infection and treatment
of high risk patients does not influence numbers of hos-
pitalizations [2]. Hence, the need to further understand
mechanisms of virus-host interactions and host immune
responses is evident.
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negative RNA genome that encodes a total of 9 struc-
tural and 2 non-structural proteins that are present in
the infected cells only. The virus infects the upper and
lower respiratory epithelium and is transmitted by either
virus laden airosols or direct contact with infected
mucus secretions. Attachment of the virus particle to
the target cell is mediated by the surface glyco (G) pro-
tein via binding to glycosaminoglycans on the host cell
surface [3-5]. Subsequent fusion of virus and cell mem-
brane is catalyzed by the fusion (F) protein [6]. The
nucleocapsid formed by the viral ss(-) RNA genome that
is entirely complexed by the nucleocapsid (N) protein, is
immediately released to the cell cytoplasm following
viral and host cell membrane fusion. Transcription of
viral mRNA is initiated immediately after fusion and
nucleocapsid release. Whereas transcription and replica-
tion of the viral ss(-)RNA genome are catalyzed by the
viral RNA dependent RNA polymerase, synthesis of viral
proteins is conducted by the host cell translation
machinery. The matrix proteins (M, M2-1, M2-2) that
form the scaffold of the viral particle, have influence on
the viral polymerase activity in vitro and have been
shown to be the major players in viral assembly and
budding processes [7]. The virus also encodes for two
non-structural (NS) proteins NS1 and NS2 that are only
expressed in the infected cell but are not present in the
mature viral particles. Assembly of viral particles occurs
presumably at raft locations in the plasma membrane
since viral proteins associate with detergent resistant
membrane regions [8,9] and lipid raft markers can be
detected in viral particles [10,11]. Viral proteins are
encoded on the genome in the following manner: 3’-
NS1-NS2-N-P-M-SH-G-F-(M2-1/M2-2)-L-5’ [12-14]
and transcription occurs in a sequential polar fashion
from 3’ to 5’ which leads to a higher abundance of pro-
teins encoded close to the 3’-end in the infected cell.
RSV infection is detected by pattern recognition
receptors of the host cell that allow initiation of pri-
mary antiviral responses. Viral RNA has been shown
to be detected by RIG-I and Toll-like receptor (TLR) 3
[15,16], and RSV-F protein is able to activate TLR4
signalling [17-19] and increase TLR4 expression [20].
Also, RSV has been shown to counterbalance cellular
antiviral responses to infection. TLR3 and TLR7
responses have been shown to be disrupted during
infection [21] and both NS1 and NS2 have been shown
to negatively regulate type I interferon response
[22-24]. The NS1 protein can interact with cellular
elongin C and cullin 2 to form an E3 ligase complex
that directs ubiquitination and degradation of signal
transducer and activator of transcription (STAT) 2, a
downstream target of the type I interferon signalling
cascade [25].
Here we present the results of a label-free quantitative
proteomic comparison of the proteome of RSV infected
versus mock-infected HEp2 cells. Analysis of this data
on a systems level revealed major changes of proteins
involved in central cellular signalling and metabolic
pathways during infection, in particular biosynthesis and
metabolism of proteins. Further validation of two indivi-
dual proteins that were found regulated was performed
using qRT-PCR and immunoblotting techniques.
Methodology
Virus infection, purification and titer determination
HEp2 cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, 10 units/ml Penicillin
and 0.1 mg/ml Streptomycin (all components from
Sigma-Aldrich) at 37°C and 5% CO2.
For RSV (subtype A strain long) stock preparation,
cells were infected at a multiplicity of infection (MOI)
of 1 in FBS free medium. Cell supernatants were
replaced with medium containing 0.5% FBS 4 hours
post infection (hpi) to remove remaining inactive viral
particles. 48 hpi cells were scraped off the flask and
supernatants were cleared by centrifugation for 5 min at
300 g. Virus containing supernatans were immediately
sterile filtered (0.45 nm) and subsequently ultracentri-
fuged at 50,000 g for 2 h at 4°C on a 10% sucrose cush-
ion to pellet viral particles. Virus pellets were
resuspended in icecold 10% sucrose in PBS and stored
at -80°C [26]. Viral titers were determined in a 96 flat
well format by infection of 5000 cells/well using 10-fold
serial dilutions of the virus preparations in 100 μl med-
ium containing 0.5% FBS. 48 hpi cells were washed,
fixed in methanol and immunostained using a monoclo-
nal antibody directed against RSV-P (clone 3C4) [27]
followed by incubation with a secondary anti-mouse Fc
antibody coupled to horseradish peroxidase (HRP) pro-
duced in goat (Dako). Visualization of bound antibodies
was performed using the 3-Amino-9-ethylcarbazole
(AEC) staining kit (Sigma). The described purification
procedure resulted in viral stock solutions of an average
concentration of 5·10
6 to 2·10
7 plaque forming units
(pfu) per ml. Infection of cells for both mass spectrome-
t r ya n a l y s i sa n dR S Vt i m ec o u r s ee x p e r i m e n t sw a sc o n -
sistently performed at a calculated MOI of 2 using
purified viral stocks.
UPLC-MS
E analysis
8·10
6 HEp2 cells were either infected with RSV or incu-
bated in infection medium lacking the virus. Cells were
lysed 24 hpi in lysis buffer (50 mM Tris, pH 7.4, 150
mM NaCl, 5 mM MgCl2, 0.5% Ipegal CA-630, 2 mM
DTT, 0.5 mM EDTA) for 15 min at 4°C. Lysates were
cleared by centrifugation at 5000 g for 10 min. Total
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(Pierce). A total of 1 mg protein of each sample was
separated by one-dimensional isoelectric focussing using
an offgel fractionater (Agilent) supplemented with pH 4
to 7 gradient strips. An aliquot of each fraction was ana-
lyzed on NuPAGE 4-12% gradient gels (Invitrogen) and
proteins were visualized by silver staining (SilverSnap,
Pierce). Remaining protein material was precipitated
with Methanol/Chloroform [28] and protein pellets
obtained were resuspended in 100 μl6MU r e ai n1 0 0
mM Tris, pH 7.8. Following reduction with 10 mM
DTT, cystein residues were alkylated using a final con-
centration of 40 mM iodoacetamide for 30 min at room
temperature. Samples were diluted with water to a final
urea concentration of 0.67 M and trypsin was added in
a 1:20 ratio regarding the total protein content of the
sample. Digestion was carried out at 37°C over night.
Following acidification with formic acid (0.1% final con-
centration), obtained tryptic peptides were purified on a
C18 reverse phase column (SepPak, Waters), dried and
resuspended in 20 μl2 %a c e t o n i t r i l e ,0 . 1 %f o r m i ca c i d
in water. Peptides were analyzed using nano-ultra per-
formance liquid chromatography coupled to electrospray
ionisation mass spectrometry (UPLC-MS
E,w h e r eE
refers to low/high collision energy switching) on a
Waters quadrupole time-of-flight (Q-tof) Premier
instrument as previously described [29]. Each fraction
was run in triplicates to allow determination of the sig-
nificance of quantitation of detected peptides. Proces-
sing of the raw data including deisotoping and
deconvolution was performed with Protein Lynx Glo-
bal Server (PLGS) 2.3 (Waters). For MS
E data MS/MS
spectra were reconstructed by combining all precursor
and fragment masses with identical retention times.
The mass accuracy of the raw data was corrected using
Glu-fibrinopeptide (200 fmol/μl; 700 nl/min flow rate;
785.8426 Da [M + 2H]
2+)t h a tw a si n f u s e di n t ot h e
mass spectrometer as a lock mass during analysis
(every 30 seconds). Peptides and regarding proteins
were identified by searching the peaklists against a
database containing all human UniProt/SwissProt
entries [version 2009.04.23; 19713 entries] combined
with all NCBI entries for RSV subtype A proteins
[2009/05/06; 208 entries] with the following para-
meters: Minimum fragment ion matches per peptide:
3; minimum fragment ion matches per protein: 7;
minimum peptide matches per protein: 1; maximum
protein mass: 250000 Da; primary digest reagent: tryp-
sin; missed cleavages: 1; fixed modifications: Carbami-
domethyl (C); variable modifications: Oxidation (M);
false positive rate: 4%. All protein hits that were identi-
f i e dw i t hac o n f i d e n c eo f> 9 5 %w e r ei n c l u d e di nt h e
quantitative analysis. Identical peptides from each tri-
plicate set per sample were clustered based on mass
precision (<10 ppm, typically ca 5 ppm) and a reten-
tion time tolerance of <0.25 min using the clustering
software included in PLGS 2.3. If two or more distinct
proteins shared an identical peptide but were found to
be regulated differently, then the quantitation algo-
rithm did not include the peptide in question. In order
to allow for this, peptide probabilities are always sof-
tened by the PLGS software slightly prior to quantita-
tion. Because of this, the contributions from peptides
with even 100% probability of presence were sup-
pressed in order to avoid potential errors in quantita-
tion. Normalisation was performed using the PLGS
„auto-normalization” function. The statistical signifi-
cance of relative expression ratios was calculated using
a Monte-Carlo algorithm and expressed as p < 0.05 for
down-regulated and 1-p > 0.95 for up-reguated pro-
teins, respectively. Ingenuity pathway analysis (IPA)
was performed with a final list of 853 proteins using a
regulation cutoff filter of 28%. The significance of cel-
lular functions and pathways relevant in RSV infection
were calculated using the right-tailed Fisher Exact Test
by considering the number of detected proteins that
are regulated in the pathway and the total number of
proteins that are associated with that pathway in the
Ingenuity Knowledge Base.
Microscopy
HEp2 cells were infected with RSV or left uninfected
and fixed in methanol at different times post infection.
Phase contrast images of were taken using a wide-field
inverted Nikon TE2000U fluorescence microscope fitted
with a 20× long working distance objective and colour
video camera.
SDS PAGE and Immunoblotting
HEp2 cells were infected with RSV or left uninfected
and harvested at different time points post infection.
Cells were lysed as described above and proteins were
separated on NuPAGE 4-12% gradient gels (Invitrogen)
and transferred to PVDF membranes for subsequent
immunoblotting. Primary antibodies used were: mouse
monoclonal aRSV-P (clone 3C4) (diln: 1:250 IF, 1:1000
WB) and mouse monoclonal aRSV-F (clone 18F12)
(diln: 1:1000) [27]; goat polyclonal aRSV particles
(Abcam, ab20745) (diln: 1:1000); rabbit polyclonal
aIFIT3 (Abcam, ab76818) (diln: 1:1000); rabbit poly-
clonal aXRN2a/b (Abcam, ab72181) (diln: 1:2500); rab-
bit polyclonal aXRN2a (Abcam, ab72284) (diln:
1:2000). Secondary HRP coupled antibodies were
o b t a i n e df r o mD a k o( d i l n :1 : 1 0 0 0 0 ) .H R Pc o u p l e d
aGAPDH (diln: 1:35000) and ab-actin (diln: 1:25000)
were purchased from Sigma. Detected proteins were
visualized using enhanced chemiluminescence (ECL-
plus, Amersham).
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HEp2 cells were infected with RSV or left uninfected and
harvested at different time points post infection. Total
RNA was extracted using the RNeasy Plus Mini Kit (Qia-
gen). A total of 4.5 μg RNA was reverse trancribed using
the ThermoScript™ Reverse Transcriptase (Invitrogen).
Quantitative real time PCRs were performed using the
QuantiTect SYBR Green RT-PCR Kit (Qiagen). An
equivalent of 20 ng cDNA as template was analyzed in tri-
plicates on a ABI StepOnePlus Real-Time PCR System
(Applied Biosystems) [30]. Specific primers used derived
from http://primerdepot.nci.nih.gov/ were: XRN2a: (5’-
TGGATTAGGTTTACTGGCATCA-3’;5 ’-GCAAG-
TACCCGTCCATCATAG-3’); IFIT3: (5’-AAGTTC-
CAGGTGAAATGGCA-3’;5 ’-TCGGAACAGCAGAGA
CACAG-3’); b-actin: (5’-CCTGGCACCCAGCACAAT-3’;
5’-GGGCCGGACTCGTCATACT-3’)
Results
Time course analysis of RSV infection reveals completed
viral protein synthesis and minor cytopathic effect 24 hpi
This study aimed to display a final state of the structure of
the reprogrammed cell proteome which requires com-
pleted synthesis of all viral proteins in the host cell. At the
same time, a cytopathic effect (CPE) on the cells caused by
viral infection should ideally be minimal. In order to estab-
lish the most suitable time point for proteomic analysis,
we hence monitored the kinetics of viral protein synthesis
and visible CPE during RSV replication by immunoblot-
ting and phase contrast microscopy, respectively. As
synthesis of viral components was completed in less than
2 4h o u r sp o s ti n f e c t i o n( h p i )( F i g u r e1 A )a n dt h ev i s i b l e
CPE of infected cells was minor (Figure 1B), this time
point was consequently used for the quantitative compari-
son of the infected and uninfected HEp2 cell proteome.
Proteomics profiling of RSV infected cells results in
identification of 1352 unique cellular and 7 viral proteins
The workflow is summarized in Figure 2. HEp2 cells
were either infected with RSV or incubated in infection
medium without addition of purified active virus parti-
cles. Cells were lysed 24 hpi and proteins were separated
by one-dimensional isoelectric focussing using an offgel
fractionater into 24 individual fractions each. Each frac-
tion comprises a particular confined pH range and pro-
teins migrate under applied voltage along a pH gradient.
A comparable separation of the cellular proteome under
both conditions was achieved and confirmed by analysis
of an aliquot of the resulting fractions by SDS-PAGE and
subsequent silver staining (Figure 3A). All fractions were
individually subjected to in-solution trypsin digestion and
peptides were purified and analyzed by UPLC-MS
E. Each
fraction was run in triplicates and only protein hits that
were confirmed in 2 out of 3 MS runs were included in
the analysis [29]. Relative quantitative comparison was
performed in a label-free fashion and based on peptide
precursor ion intensities [31]. Comparison was carried
out between detected proteins of a certain fraction to the
regarding control fraction of the same pH range.
We observed identification of many proteins in more
than one offgel fraction, which can be explained by two
main conditions. Firstly, many proteins occur in multi-
ple isoforms or variants within the cell due to either
alternative splicing events of the regarding mRNA, post-
transcriptional RNA editing, proteolytic processing and/
or post-translational modifications. These variants
migrate into distinct fractions during pH-dependent
fractionation due to their altered isoelectric point (pI).
Secondly, highly abundant proteins might not quantita-
tively separate into a single fraction but rather distribute
throughout neighbouring fractions.
In total, 3134 cellular protein hits of 1352 unique cellu-
lar proteins were detected in 20 analyzed fractions. For
2432 protein hits a quantitative expression ratio was calcu-
lated (Figure 3B). We identified 7 out of 11 viral proteins
that were, as expected, unique to infected cells (table 1).
IPA analysis reveals cellular pathways that are interrupted
by RSV infection
Ingenuity pathway analysis (IPA) was used for analysis
of this data on a systems level. IPA requires expression
Figure 1 RSV time course of infection.H E p 2c e l l sw e r ei n f e c t e d
with RSV and harvested at indicated time points post infection. (A)
Cells were lysed and proteins analyzed by SDS-PAGE and subsequent
immunoblotting using a polyclonal antibody raised against whole RSV
particle lysates or monoclonal antibodies directed against the RSV-F
and RSV-P protein. (B) Phase contrast images of RSV infected HEp2
cells at indicated time points post infection.
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Therefore, proteins that were identified in one condition
only had to be assigned a virtual regulation factor. For
our dataset the quantitative expression ratio for proteins
identified in either condition was set to 3-fold up- or
down-regulation [ln(R) = +/- 1.10, were R is the protein
expression ratio which is calculated by the sum of pep-
tide intensities in RSV versus mock-infected cells]
according to the actual maximal detected experimental
regulation values (Figure 3B). In addition, multiple regu-
lation factors obtained for one unique protein detected
in distinct fractions had to be reduced to a single value.
S i n c ew em a n u a l l ys e tr a t i o sf o rp r o t e i n st h a tw e r e
found in either condition only to ln(R) = +/- 1.10, calcu-
lation of an average or mean regulation value could lead
to a false emphasis on either condition. Therefore, we
decided to delete all multiplicate protein entries that
had controversial regulation values throughout different
fractions for IPA analysis. As general rule, we deducted
multiplicate protein hits if one or more detected loga-
rithmic ratios was of opposite algebraic sign or equal to
zero. For remaining multiplicates that showed a com-
mon trend for all detected data points, the minimal reg-
ulation factor detected was chosen for IPA analysis.
Amendment of the data resulted in a final list of 853
proteins, of which 380 were regulated more than 28%
(ln(R) = +/- 0.25).
Analysis of this amended dataset by IPA associated
regulated proteins to cellular functional classes defined
by the Ingenuity knowledge database. Disease specific
functions included ‘respiratory disease’ (22 proteins, P-
values 5.77·10
-4 to 2.06·10
-2)a n d‘infectious disease’ (31
proteins, P-values 8.64·10
-6 to 4.82·10
-2), in which 25
molecules were correlated to ‘infection of cell lines’.
‘Protein synthesis’ (25 proteins, P-values 8.80·10
-8 to
3.31·10
-2) was noted as most significant cell function
affected which reflects the impact of viral infection on
exploiting this host cell function to implement protein
Figure 3 Quality control of fractionation and obtained quantitative data. (A) Proteins were separated by SDS-PAGE and visualized by
subsequent silver staining. SDS-PAGE analysis of the offgel fractions shows successful separation of protein on the pH strip and indicates
differences in the proteome of infected versus uninfected cells. (B) All obtained logarithmic protein expression ratios, ln (R), were plotted in
ascending order for each identified protein (protein id) along the x-axis. Dotted horizontal bars indicate the chosen cutoff for up- and down-
regulation during RSV infection used in IPA analysis, respectively.
Figure 2 Label-free profiling workflow.R S Vi n f e c t e da n d
uninfected HEp2 cells were lysed and proteins were separated by
isoelectric focussing using offgel fractionation. Following tryptic
digestion, purified peptides were characterized by UPLC-MS
E and
subsequent relative quantitative expression profiling.
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Page 5 of 13Figure 4 Canonical pathways regulated during RSV infection. (A) Selected canonical pathways identified by IPA as regulated during RSV
infection plotted by their significance. Yellow data points display the ratio of detected regulated proteins and proteins defined in the pathway.
(B) Schematic plots of JAK/STAT and Interferon type I signalling pathways. Proteins that were found regulated during RSV infection are
highlighted in green (down-regulated during infection) or red (up-regulated during infection); grey colour indicates regulation below 28%.
Table 1 RSV proteins identified
NCBI Accession # Gene name PLGS score fr# r pep# % cov
gi|133667|sp|P12579|PHOSP_HRSVL Phosphoprotein; Short = P 1465.7 4 d 14 47.7
gi|138896|sp|P04544|NS1_HRSVA Non-structural protein 1; Short = NS1 285.2 14 d 4 61.9
gi|127889|sp|P03418|NCAP_HRSVA Nucleoprotein; Short = Protein N 346.2 17 e 12 40.4
gi|1353203|sp|P20895|GLYC_HRSVL Major surface glycoprotein G; Short: Protein G 134.2 17 d 4 27.9
gi|138252|sp|P12568|FUS_HRSVL Fusion glycoprotein F0; Short = Protein F 324.4 17 d 5 13.8
gi|137260|sp|P04545|M21_HRSVA Matrix M2-1 584.4 19 e 6 23.3
gi|138727|sp|P03419|MATRX_HRSVA Matrix protein 266.1 23 f 11 49.2
fr#: Offgel fraction in which the protein was identified with highest score
r: representative replicate of the fraction in which the protein was detected (a,b,c non infected; d,e,f infected)
pep#: number of peptides detected
% cov.: detected peptide coverage of protein sequence in %
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Page 6 of 13synthesis. Biosynthesis and metabolism of proteins were
the two most influenced subsections of protein synthesis
that were regulated. Accordingly, eukaryotic initiation
factor 4E (eIF4E) signalling was the cellular pathway
found with highest regulation significance. Furthermore,
regulation of other central cellular canonical signalling
pathways including ‘PI3K/Akt signalling’, ‘mTOR signal-
ling’, ‘protein ubiquitination pathway’, ‘ERK/MAPK sig-
nalling’,a n d‘RAN signalling’ was listed by IPA analysis
(Figure 4A). Additionally, multiple metabolic canonical
pathways were identified to be impaired by viral infec-
tion, including ‘one carbon pool by folate’, ‘aminosugars
metabolism’,a n d‘glutathione metabolism’ (Figure 4A).
Interferon induced ‘JAK/STAT signalling’ was identified
to be differentially regulated by extracellular signal-regu-
lated kinase (ERK) 1 and 2 up-regulation on the one
hand and phosphoinositide-3-kinase (PI3K) down-regu-
lation on the other hand (Figure 4B). The central regula-
tory cellular molecules of selected pathways that were
assigned by IPA are listed in table 2. These results
reflect the broad influence of RSV infection on major
signalling pathways in the cell.
IFIT3 and XRN2 mRNA synthesis is up-regulated during
RSV infection in a time dependent manner
Two individual proteins that were up-regulated in
infected cells were further analyzed for dynamics of reg-
ulation during infection. Firstly, a target gene of Inter-
feron type I signalling, Interferon stimuated protein with
tetratricopeptide repeats 3 (IFIT3) (490 aa; 56,0 kDa),
was found up-regulated 3-fold in infected cells (Figure
4B, table 2). IFIT3 is induced upon interferon stimula-
tion and has been described regulated during several
RNA viral infections in microarray analyses [32-36]. A
second interesting target which was detected in infected
cells only is 3’-5’ exoribonuclease 2 (XRN2) (table 2).
XRN2 has been described to participate in cellular tran-
scription termination [37-39] and processing of riboso-
mal RNAs [40]. There are two known isoforms of
XRN2, namely XRN2a (950 aa; 108,6 kDa), which is the
fully translated protein, and XRN2b (874 aa; 100,0 kDa),
that lacks the first N-terminal 76 amino acids.
To determine the mRNA expression levels of these two
proteins during RSV infection, we performed quantitative
real-time PCR (qRT-PCR) experiments of RNA extracted
from cells that were harvested at several different time
points post RSV infection. IFIT3 and XRN2a mRNAs were
found to accumulate up to approximately 100-fold during
RSV infection in a time dependent manner (Figure 5).
Immunoblotting confirmes up-regulation of IFIT3 and
suggests the presence of modified XRN2 during RSV infection
According to the accumulation of IFIT3 mRNA, analysis
of whole cell lysates by immunoblotting also confirmed
accumulation of IFIT3 protein during infection over
time (Figure 6A). To our surprise, immunoblotting
using antibodies directed against either the C- (ab72181)
or N-terminus (ab72284) of XRN2 led to detection of a
single band of approximately 110 Da that was expressed
in constant amounts throughout the time course of
infection (Figure 6B). According to the molecular weight
detected, we concluded that the detected isoform is
XRN2a. We further analyzed the distribution of XRN2
throughout the individual offgel fractions and confirmed
the presence of XRN2 in fraction 17 exclusively in
infected cells in agreement with the MS results. In addi-
tion, equal levels of XRN2 in both mock-infected and
infected cells were detected in the neighbouring fraction
1 6( F i g u r e6 C ) .W et h e r e f o r ec o n c l u d et h a tX R N 2i s
most likely modified during RSV infection in a way that
results in a pI shift of the protein to a slightly more
basic pH. At the same time, the electrophoretic mobility
of XRN2 is not notably altered by this modification and
thereby escapes detection in unfractionated whole cell
lysate analyses.
Discussion
Recently, proteomic approaches have been exploited to
investigate changes in the cellular proteome during RSV
infection. A study that analyzed nuclear extracts of RSV
infected cells by two-dimensional gel electrophoresis
and subsequent MALDI-TOF MS analysis identified reg-
ulation and reorganisation of proteins associated with
the nuclear domain 10 (ND10), in particular up-regula-
tion of TAR DNA binding protein and reorganisation of
promyelocytic leukemia protein (PML) and speckled 100
kDa protein (Sp100) [41]. Additionally, heat shock pro-
tein 70 (Hsp70) redistribution and accumulation to the
nucleus was described upon RSV infection. Interestingly,
Hsp70 has been shown to also relocate into lipid raft
membrane structures during RSV infection [42] and has
been found to be incorporated into viral particles [43].
In our study, we concentrated on cytoplasmic fractions
of infected cells and therefore did not detect the
described changes in ND10 composition. However, we
identified Hsp70 in 12 distinct offgel fractions of which
11 fractions showed higher abundance of the protein in
infected cells. This data supports the hypothesis that
RSV infection leads to redistribution of Hsp70 into the
cytoplasm (data not shown). A SILAC study of cytoplas-
mic and nuclear cell extracts of RSV infected lung carci-
noma cells (A549) validated changes in ND10 structures
and furthermore highlighted novel changes in mitochon-
drial protein expression patterns [44]. Changes in the
disease associated cellular functions ‘respiratory disease’
and ‘infectious disease’ and the cellular pathway ‘RAN
signalling’ were observed according to our results. An
independent study using 2-D Fluorescence Difference
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Page 7 of 13Table 2 Overview of regulated proteins and associated pathways in RSV infection
Pathway/
Protein
Swiss Prot
#
Gene Name ln (R) R PLGS
Score
fr# r pep # %
cov
JAK/STAT
GRB2
3 P62993 growth factor receptor-bound protein 2 0.25 1.28 432.2 17 a 13 71.0
ERK1¹ P27361 extracellular signal-regulated kinase 1 RSV RSV 326.1 21 e 9 33.8
ERK2¹ P28482 etracellular signal-regulated kinase 2 0.36 1.43 390.6 24 a 18 54.4
PIK3R2
2 O00459 phosphoinositide-3-kinase, regulatory subunit 2 (beta) mock mock 758.6 19 a 23 45.2
Regulation of eIF4 and p70S6K (includes protein # 1,2,3)
EIF1AX P47813 eukaryotic translation initiation factor 1A, X-linked -0.43 0.65 346.6 10 a 3 27.8
EIF1AY O14602 eukaryotic translation initiation factor 1A, Y-linked -0.37 0.69 367.2 10 a 7 47.2
EIF2B2 P49770 eukaryotic translation initiation factor 2B, subunit 2 beta -0.35 0.70 476.2 19 a 12 45.9
EIF3C
7 Q99613 eukaryotic translation initiation factor 3, subunit C RSV RSV 268.6 15 e 5 6.4
EIF3E
7 P60228 eukaryotic translation initiation factor 3, subunit E -0.40 0.67 462.1 15 a 12 40.2
EIF4E
4 P06730 eukaryotic translation initiation factor 4E -0.48 0.62 176.0 17 b 5 31.3
ITGA5
5 P08648 integrin, alpha 5 0.37 1.45 678.2 4 a 9 10.9
PP2R2B
6 Q00005 protein phosphatase 2, regulatory subunit B, beta mock mock 441.0 19 a 7 22.3
RPS6
7 P62753 ribosomal protein S6 RSV RSV 176.7 17 d 5 23.3
ERK/MAPK (includes protein # 1,2,3,4,5,6)
CRKL P46109 Crk-like protein mock mock 308.7 19 a 9 45.5
PAK1
9 Q13153 p21 protein (Cdc42/Rac)-activated kinase 1 -0.31 0.73 641.9 17 a 9 26.6
PPP1R14B Q96C90 protein phosphatase 1, regulatory (inhibitor) subunit 14B -0.59 0.55 270.7 7 a 4 38.1
RAC1
8 P63000 ras-related C3 botulinum toxin substrate 1 -0.32 0.73 163.5 21 b 3 24.0
RAC2 P15153 ras-related C3 botulinum toxin substrate 2 mock mock 149.9 21 a 4 31.8
mTOR (includes protein # 1,2,4,6,7,8)
AKT1S1 Q96B36 AKT1 substrate 1 (proline-rich) -0.29 0.75 163.9 4 a 4 20.7
PLD3 Q8IV08 phospholipase D family, member 3 mock mock 222.5 22 a 9 19.6
RHOJ Q9H4E5 ras homolog gene family, member J -0.38 0.68 150.9 21 b 3 22.9
AKT (includes protein # 1,2,3,4,5,6)
CTNNB1 P35222 catenin (cadherin-associated protein), beta 1 RSV RSV 507.3 17 e 12 22.3
HLA-B
10 P30484 major histocompatibility complex, class I, B -0.38 0.68 465.8 20 b 5 16.6
RAC (includes protein # 1,2,5,8,9)
ARPC5
12 O15511 actin related protein 2/3 complex, subunit 5 0.27 1.31 333.6 14 a 6 41.7
ARPC5L
12 Q9BPX5 actin related protein 2/3 complex, subunit 5-like 0.31 1.36 261.0 19 a 7 66.0
IQGAP1 P46940 IQ motif containing GTPase activating protein 1 mock mock 1092.7 15 a 41 39.2
RAN
CSE1L P55060 chromosome segregation 1-like protein (exportin 2) mock mock 559.9 20 a 17 29.6
IPO5 O00410 importin 5 RSV RSV 168.6 7 e 8 9.2
Clathrin mediated Endocytosis (includes protein # 2,3,5,8,12)
CTTN Q14247 cortactin mock mock 356.7 12 a 24 42.9
PPP3CA Q08209 protein phosphatase 3, catalytic subunit, alpha isozyme -0.30 0.74 357.0 17 a 8 19.8
SH3GLB1 Q9Y371 SH3-domain GRB2-like endophilin B1 mock mock 349.2 15 a 3 9.9
TSG101 Q99816 tumor susceptibility gene 101 mock mock 271.2 19 a 6 17.4
Protein Ubiquitination (includes protein # 10)
B2M P61769 beta-2-microglobulin 0.56 1.75 352.1 21 a 3 37.8
BAG1 Q99933 BCL2-associated athanogene mock mock 515.4 10 a 14 47.8
DNAJA1 P31689 DnaJ (Hsp40) homolog, subfamily A, member 1 RSV RSV 233.5 24 d 13 36.8
DNAJB11 Q9UBS4 DnaJ (Hsp40) homolog, subfamily B, member 11 0.25 1.28 601.3 19 a 12 43.0
HLA-C Q95604 major histocompatibility complex, class I, C -0.35 0.70 390.6 20 b 7 30.9
PSMC5 P62195 proteasome 26S subunit, ATPase, 5 RSV RSV 355.9 24 d 15 42.6
PSMD5 Q16401 proteasome 26S subunit, non-ATPase, 5 -0.32 0.73 1246.8 12 a 26 41.4
SKP1 P63208 S-phase kinase-associated protein 1 -0.32 0.73 999.1 4 a 9 46.6
TCEB1 Q15369 transcription elongation factor B (SIII), pp 1 (elongin C) -0.29 0.75 630.9 5 a 7 66.1
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Page 8 of 13Gel Electrophoresis (2-D DIGE) and subsequent MS
analysis revealed similar cellular proteome changes upon
infection with different Paramyxoviruses. This study
emphasizes the influence of viral infection on induction
of apoptosis and the cellular stress response [45].
We used a label-free quantitative proteomic approach
to analyze changes of the cellular proteome during RSV
infection. In order to improve identification of low
abundance proteins, we separated complex whole cell
lysates by protein offgel fractionation prior to MS
analysis. Our findings emphasize the benefits and chal-
lenges of quantitative data analysis using this approach.
Since to date quantitation is limited to each fraction
separately, obtained relative protein expression ratios
reflect the change in abundance of a subpopulation of a
protein group that inherits a confined isoelectric point.
This approach can therefore generally improve the data-
set of studies that aim to include regulation of protein
modification in addition to changes in total protein
abundance. This could be advantageous for analysis of
Table 2 Overview of regulated proteins and associated pathways in RSV infection (Continued)
TCEB2 Q15370 transcription elongation factor B (SIII), pp 2 (elongin B) RSV RSV 163.7 5 d 8 89.8
UBE2F Q969M7 ubiquitin-conjugating enzyme E2F RSV RSV 118.4 22 e 4 22.2
UBE2G2 P60604 ubiquitin-conjugating enzyme E2G 2 mock mock 120.4 5 b 3 27.9
USP11 P51784 ubiquitin specific peptidase 11 -0.32 0.73 643.5 10 a 30 49.2
Interferon
IFIT3 O14879 Interferon-induced protein with tetratricopeptide repeats 3 1.09 2.97 441.8 10 b 14 48.2
Glycolysis
ACSS2
11 Q9NR19 acyl-CoA synthetase short-chain family member 2 mock mock 277.5 21 a 8 17.1
ALDH1A1 P00352 aldehyde dehydrogenase 1 family, member A1 RSV RSV 370.0 17 d 7 30.5
ALDH1A2 O94788 aldehyde dehydrogenase 1 family, member A2 RSV RSV 281.6 17 d 9 31.5
ALDH1A3 P47895 aldehyde dehydrogenase 1 family, member A3 RSV RSV 396.4 23 d 15 49.6
GALK1
13 P51570 galactokinase 1 -0.31 0.73 1066.4 19 a 17 55.6
PKLR P30613 pyruvate kinase, liver and RBC RSV RSV 515.0 17 d 7 16.6
One Carbon Pool by Folate
GCSH P23434 glycine cleavage system protein H mock mock 189.5 4 a 3 25.4
MTHFD1 P11586 methylenetetrahydrofolate dehydrogenase (NADP+ dep.) 1 mock mock 695.6 24 a 27 39.3
MTR Q99707 5-methyltetrahydrofolate-homocysteine methyltransferase mock mock 1141.5 14 b 35 36.5
TYMS P04818 thymidylate synthetase -0.26 0.77 338.3 24 a 12 38.3
Aminosugars Metabolism (includes protein # 13)
GFPT2 O94808 glutamine-fructose-6-phosphate transaminase 2 RSV RSV 654.1 23 d 16 33.4
HEXA P06865 hexosaminidase A (alpha polypeptide) -0.37 0.69 160.6 7 a 8 14.4
HEXB P07686 hexosaminidase B (beta polypeptide) mock mock 265.4 22 a 10 16.7
NAGK Q9UJ70 N-acetylglucosamine kinase -0.55 0.58 324.8 17 a 12 52.9
PDE12 Q6L8Q7 phosphodiesterase 12 RSV RSV 310.9 17 d 13 26.3
Aminoacyl tRNA Biosynthesis
FARSA Q9Y285 phenylalanyl-tRNA synthetase, alpha subunit RSV RSV 243.5 24 d 12 29.5
KARS Q15046 lysyl-tRNA synthetase -0.28 0.76 651.6 7 a 24 38.4
SARS2 Q9NP81 seryl-tRNA synthetase 2, mitochondrial 0.57 1.77 626.4 23 a 22 51.0
Gluthathion Metabolism (includes protein # 11)
GCLM P48507 glutamate-cysteine ligase, modifier subunit -0.54 0.58 398.5 16 a 7 32.8
GSTM2 P28161 glutathione S-transferase mu 2 RSV RSV 222.9 12 e 10 43.6
GSTM3 P21266 glutathione S-transferase mu 3 -0.25 0.78 372.1 12 a 13 61.3
GSTO1 P78417 glutathione S-transferase omega 1 -0.4 0.67 645.9 19 a 16 67.2
OTHER
XRN2 Q9H0D6 5’-3’ exoribonuclease 2 RSV RSV 532.2 17 e 17 24.7
1: ERK1, ERK2; 2: PI3KR2; 3: GRB2; 4: EIF4E; 5: ITGA5; 6:PPP2R2B; 7: EIF3C, EIF3E; 8: RAC1; 9: PAK1; 10: HLA-B; 11: ACSS2; 12: ARPC5, ARPC5L; 13:GALK1
R: Protein expression ratio. Calculated by the mean of corresponding peptide intensities detected in infected versus mock-infected cells. ‘RSV’ or ‘mock’ stated in
this column indicates that the protein was detected in infected cells (RSV) or mock-infected cells (mock) only.
fr#: Offgel fraction in which the protein was identified
r: representative replicate of the fraction in which the protein was detected
pep#: number of peptides detected
% cov.: detected peptide coverage of protein sequence in %
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Page 9 of 13the influence of RNA virus infection on the cellular pro-
teome, since novel viral proteins are introduced to the cel-
lular environment and immediate changes are likely to
occur on the posttranslational level. In particular, detec-
tion of the modulation of XRN2 protein during RSV infec-
tion would have escaped detection in other quantitative
proteome studies since total XRN2 protein levels were
constant throughout infection. However, the extent to
which this complex dataset can be interpreted by global
expression analysis tools like IPA is limited and requires
manual sorting of the data prior to analysis, as otherwise
median or average values are calculated for multiple
obtained expression values of a single protein and the
actual regulation of that protein would be obliterated or
even falsified. In this study, we excluded most protein hits
for which multiplicate expression ratios were obtained
from IPA analysis to ensure integrity of the imported data-
set. This analysis resulted in identification of several cen-
tral cellular pathways that were impaired by RSV infection.
It is known that RSV infection leads to activation of
ERK1/2 [46], which is dependent on activation of TLR4
signalling and p38 mitogen-activated protein kinase
early in respiratory virus infection [47]. Additionally, it
was demonstrated that activation of ERK1/2 is required
for viral entry using Sendai virus-like particles as a
model for Paramyxovirus infection [48]. In this study,
ERK1 was identified in RSV infected cells only, and
ERK2 was detected with higher abundance in infected
cells. Since published results suggest that the levels of
t h ei n a c t i v ei s o f o r m so fE R K 1 / 2s t a yc o n s t a n tt h r o u g h -
out viral replication [48], we hypothesize that our data
may reflect the levels of the active phosphorylated iso-
forms of both kinases.
The Ubiquitination Pathway was also shown to be
highly impaired during RSV replication. It was shown
that RSV NS1 protein can recruit elongin C and cullin 2
to direct STAT2 ubiquitination and degradation [25].
Reduced levels of elongin C observed in our dataset
might represent a cellular response to counterbalance
STAT2 ubiquitination and degradation. Moreover, we
detected ubiquitin specific protease 11 (USP11) with
lower abundance in infected cells. Interestingly, antiviral
activity of USP11 was recently described in influenza A
virus replication. Monoubiquitination of the viral
nucleoprotein (NP) was shown to be required for effi-
cient replication. USP11 was able to bind and deubiqui-
tinate NP, thereby antagonizing viral replication [49].
Furthermore, the deubiquitinating enzyme OTUB1 was
detected with higher abundance in infected cells, indi-
cating a role of this protein in viral infection.
IFIT3 was classified as a member of the interferon
(IFN) inducible protein family based on its structural
homology to other members and the common clustering
of these genes at chromosome 10q23.3 [50,51]. Expres-
sion of the IFIT3 gene is regulated by two IFN-stimu-
lated response elements (ISRE) upstream of the TATA
box in its promoter region and is induced upon IFNa
stimulation [51-53]. IFIT3 has been identified as key
mediator in IFNa mediated antiproliferative responses
by enhancing both p21 and p27, two negative regulators
of cell cycle progression that control transition from G1
to the S phase. A novel mechanism of IFIT3 activation
in a STAT1 independent manner by either a STAT2/
IRF9 complex lacking STAT1 or by IRF1 alone was pro-
posed recently [54]. However, since STAT2 levels have
been shown to be significantly lowered during RSV
infection [25], the mechanism of the observed induction
of IFIT3 transcription during RSV infection remains to
be determined. Interestingly, our data also shows lower
levels of STAT1 in infected cells, as it was detected
down-regulated during infection in two fractions (fr. 16:
mock-infected cells only, fr 17: ln(R) = -0.12). In Figure
4B, STAT1 is indicated as not regulated, since
Figure 6 XRN2 and IFIT3 expression during RSV infection. HEp2
cells were infected with RSV (+) or left uninfected (-) and harvested
at indicated time points post infection. Cells were lysed and
proteins analyzed by SDS-PAGE and subsequent immunoblotting
using polyclonal antibody raised against IFIT3 (A) or either XRN2a or
XRN2a/b (B). Western blot analysis of indicated offgel fractions of a
whole cell lysate of RSV infected cells 24 hpi using a polyclonal
antibody raised against XRN2a (C).
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Page 10 of 13amendment of the data let to inclusion of the minimal
regulation factor, and the identification in fraction 16 of
mock-infected cells only was discarded for IPA analysis.
Antiviral activity of IFIT3 was demonstrated recently, as
the growth of several RNA viruses was enhanced in cells
in which IFIT3 expression was reduced by siRNA trans-
fection [55,56]. Furthermore, IFIT1, a member of the
IFIT family, can recognize 5’-triphosphate RNA and has
been shown to form a complex with both IFIT2 and
IFIT3 [56]. Therefore it will be of great interest to study
the functionality of IFIT3 in further detail.
While the immediate function of IFIT3 remains
unknown, XRN2 exerts an exoribonuclease activity that
is involved in the torpedo model of polymerase II tran-
scriptional termination [37-39]. Recently, evidence for
its role in yeast polymerase I transcription termination
has been provided [57]. Additionally, human XRN2 has
been shown to be essential for ribosomal RNA matura-
tion and degradation [40]. Linkeage of the XRN2 protein
to immune pathways has been given by it’s interaction
with the Toll interacting rotein TOLLIP [58] that plays
an inhibitoy role in Toll-like receptor signalling.
We observed accumulation of XRN2 mRNA levels
during the time course of RSV infection in a time
dependent manner. In contrast, subsequent immuno-
blotting experiments in cell extracts using antibodies
against the two known isoforms of XRN2 did not con-
firm an increase in protein levels during infection. How-
ever, our data indicates that XRN2 undergoes specific
modification(s) during RSV infection that lead to a shift
of the protein towards a more basic pI. Possible expla-
nations for the discrepancy between mRNA and protein
levels are repression of mRNA processing, enhanced
p r o t e i nt u r n o v e ro rac o n f i n ed cellular localization of
XRN2. Clearly, this warrants further investigation as our
data provides evidence for tight regulation and of XRN2
during the time course of RSV infection.
Conclusion
Quantitative analysis of the proteome of RSV infected
versus uninfected cells by UPLC-MSE resulted in identi-
fication of 1352 unique cellular proteins. IPA analysis
revealed several cellular pathways that are interrupted
by viral infection. Further analysis of IFIT3 and XRN2
that were found to be up-regulated during infection
were validated on the transcriptional level. While IFIT3
protein levels accumulated accordingly, XRN2 protein
expression was constant but showed modification(s)
unique to infected cells. In summary, analysis of the
specific functions of both IFIT3 and XRN2 during RNA
viral replication will be of great value to further unravel
mechanisms of RNA virus replication and the cellular
antiviral response.
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